News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Staff Question Data on GlaxoSmithKline (GSK), Genmab, Inc. (GNMSF.PK) Drug



5/27/2009 8:23:43 AM

Bookmark and Share

Reuters -- U.S. drug reviewers have questioned if a proposed leukemia drug from GlaxoSmithKline PLC and Genmab provides enough benefit to warrant approval, documents released on Wednesday said.


Read at Reuters


comments powered by Disqus
Reuters
   
Leukemia

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES